CRYL1 and neoplasm: Dysregulation of circadian rhythm genes—such as CLOCK, BMAL1, PER, and CRY—may result in abnormal proliferation, metabolic reprogramming, genomic instability, immune evasion, and microenvironmental remodeling in HCC cells, thereby promoting tumor progression19–23.